BOLD vs MRNA · P/E 0.1, $24.6M cap vs rev $1.94B
Boundless Bio, Inc. Common Stock (BOLD) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
BOLD does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BOLD and MRNA stock pages for the full models.
Not investment advice.